Hospitals dominated the end-user segment with a market share of 44.26% in 2025, driven by high patient volumes, increasing diabetes management programs, growing obesity treatment initiatives, and greater access to specialist endocrinology services
Why Headlines and Social Media Create Confusion Across St
Huannao Yicong formula (HYF) and Jiannao Yizhi formula (JYF) reduce A42 and tau protein levels, delivering comparable benefits to standard ChEIs (Yang et al., 2019
We have documented that coverage policies vary by payer: private employer-sponsored plans are rapidly evolving (with 43% of large firms now covering GLP-1 weight drugs ( [6] )), Medicare is transitioning from outright exclusion to the BALANCE Model framework for coverage starting mid-2026 ( [5] ), and Medicaid coverage differs state by state with only 13 programs covering obesity indications as of early 2026 ( [3] ) ( [33] )
Safe for daily use by adults as part of a heart health and energy support regimen